Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines, vaccines franchises, support, and corporate functions 1973 and is headquartered in Paris, France. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1973
Founded1973
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
100.74B
Market cap100.74B
Price-Earnings ratio
21.33
Price-Earnings ratio21.33
Dividend yield
4.24%
Dividend yield4.24%
Average volume
3.81M
Average volume3.81M
High today
$41.85
High today$41.85
Low today
$41.70
Low today$41.70
Open price
$41.76
Open price$41.76
Volume
4.73K
Volume4.73K
52 Week high
$52.68
52 Week high$52.68
52 Week low
$39.07
52 Week low$39.07

SNY News

Financial Times 7h
Can French drugmaker Sanofi fix its pipeline? - Financial Times

...

Can French drugmaker Sanofi fix its pipeline? - Financial Times
24/7 Wall St. 23h
Regeneron's Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings

Investing Regeneron’s Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings Regeneron (NASDAQ:REGN | REGN Price Prediction) reports...

Regeneron's Billion-Dollar Catalyst Flying Under Wall Street’s Radar Ahead of Oct. 30 Earnings
TipRanks 4d
Sanofi’s New Oral Alzheimer’s Drug Enters Mid-Stage Trials: What Investors Should Watch

Sanofi SA (SNY) announced an update on their ongoing clinical study. Sanofi is running a mid-stage study called “A Phase 2, Randomized, Double-blind, Placebo-c...

Analyst ratings

50%

of 10 ratings
Buy
50%
Hold
50%
Sell
0%

More SNY News

TipRanks 4d
Sanofi Advances Rilzabrutinib Kidney Study, Supporting Long-Term BTK Pipeline Potential

Sanofi SA (SNY) announced an update on their ongoing clinical study. The Phase 1 study “An Open-label, Multi-center, Phase 1 Pharmacokinetic and Tolerability S...

TipRanks 5d
Sanofi Shuts Down Long-Term IBD Drug Study, Nudging Expectations for Future Growth

Sanofi (SNYNF) announced an update on their ongoing clinical study. Sanofi has ended a multinational extension study called SPECIFI-IBD-LTS, which tracked long...

TipRanks 7d
Sanofi, ScionxBio enter collaboration, licensing agreement

ScionxBio has entered into a worldwide strategic collaboration and licensing agreement with Sanofi (SNY) to develop and commercialize extended exposure versions...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.